3van Weel C,Koopmans R,van der Velden K. Bridging the gap between primary care and public health[J].Australian Family Physician,2009,(04):182-183.
4NpsfN P S F. Agenda for research and development in patient safety[M].Chicago,USA,2002.
5Budnitz D S,Layde P M. Outpatient drug safety:new steps in an old direction[J].Pharmacoepidemiology and Drug Safety,2007,(02):160-165.doi:10.1002/pds.1242.
6Gandhi T K,Weingart S N,Borus J. Adverse drug events in ambulatory care[J].New England Journal of Medicine,2003,(16):1556-1564.doi:10.1056/NEJMsa020703.
7Brook R H,Appel F A,Avery C. Effectiveness of inpatient follow-up care[J].New England Journal of Medicine,1971,(27):1509-1514.doi:10.1056/NEJM197112302852705.
8Himmel W,Tabache M,Kochen M M. What happens to longterm medication when general practice patients are referred to hospital[J].European Journal of Clinical Pharmacology,1996,(04):253-257.doi:10.1007/s002280050103.
9Chen Y F,Avery A J,Neil K E. Incidence and possible causes of prescribing pote(nn)aily hazardous/contraindicated drug combinations in general practice[J].Drug Safety,2005,(01):67-80.doi:10.2165/00002018-200528010-00005.
